MIR4425: A Drug Target / Disease Biomarker (G100616365)
MIR4425: A Drug Target / Disease Biomarker
MIR4425 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the MIR44 family of RNA-binding proteins, which are known for their ability to interact with RNA polymerases and other cellular components.
One of the unique features of MIR4425 is its ability to interact with the protein p21, which is a key regulator of the T-cell receptor signaling pathway. This interaction between MIR4425 and p21 has been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation.
In addition to its interaction with p21, MIR4425 has also been shown to interact with several other proteins, including the transcription factor NF-kappa-B. This interaction between MIR4425 and NF-kappa-B has been shown to play a role in the regulation of cellular processes such as inflammation, fibrosis, and cancer.
MIR4425 has also been shown to play a role in the regulation of gene expression. It has been shown to interact with the protein Stat3, which is a transcription factor that is involved in the regulation of cellular processes such as cell growth, apoptosis, and inflammation. This interaction between MIR4425 and Stat3 has been shown to play a role in the regulation of gene expression, including the regulation of genes involved in cell adhesion, migration, and invasion.
In addition to its interactions with p21 and NF-kappa-B, MIR4425 has also been shown to interact with several other proteins, including the protein SMAP, which is a protein that is involved in the regulation of gene expression and cell death. This interaction between MIR4425 and SMAP has been shown to play a role in the regulation of cellular processes such as cell death, stem cell maintenance, and tissue repair.
MIR4425 has also been shown to play a role in the regulation of cellular signaling pathways. It has been shown to interact with the protein S6, which is a transcription factor that is involved in the regulation of cell growth, apoptosis, and inflammation. This interaction between MIR4425 and S6 has been shown to play a role in the regulation of cellular signaling pathways, including the regulation of cell growth, apoptosis, and inflammation.
In addition to its interactions with p21, SMAP, and S6, MIR4425 has also been shown to interact with several other proteins, including the protein JNK, which is a protein that is involved in the regulation of cellular signaling pathways. This interaction between MIR4425 and JNK has been shown to play a role in the regulation of cellular signaling pathways, including the regulation of cell growth, apoptosis, and inflammation.
MIR4425 has also been shown to play a role in the regulation of cellular transport processes. It has been shown to interact with the protein TRPV4, which is a receptor that is involved in the regulation of pain perception and thermal sensitivity. This interaction between MIR4425 and TRPV4 has been shown to play a role in the regulation of cellular transport processes, including the regulation of the movement of cells and tissues.
In addition to its interactions with TRPV4, MIR4425 has also been shown to interact with several other proteins, including the protein GABA, which is a neurotransmitter that is involved in the regulation of anxiety and other cellular processes. This interaction between MIR4425 and GABA has been shown to play a role in the regulation of cellular processes such as anxiety and neurotransmission.
MIR4425 has also been shown to play a role in the regulation of cellular processes such as cell adhesion, migration, and invasion. It has been shown to interact
Protein Name: MicroRNA 4425
The "MIR4425 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4425 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4427 | MIR4428 | MIR4429 | MIR4430 | MIR4431 | MIR4432 | MIR4432HG | MIR4433A | MIR4433B | MIR4435-1 | MIR4435-2 | MIR4435-2HG | MIR4436A | MIR4436B1 | MIR4436B2 | MIR4437 | MIR4440 | MIR4441 | MIR4442 | MIR4443 | MIR4444-1 | MIR4444-2 | MIR4445 | MIR4446 | MIR4447 | MIR4448 | MIR4449 | MIR4450 | MIR4451 | MIR4453 | MIR4453HG | MIR4454 | MIR4455 | MIR4456 | MIR4457 | MIR4458 | MIR4458HG | MIR4463 | MIR4465 | MIR4466 | MIR4467 | MIR4468 | MIR4469 | MIR4470 | MIR4472-1 | MIR4472-2 | MIR4474 | MIR4475 | MIR4476 | MIR4478 | MIR4479 | MIR448 | MIR4481 | MIR4482 | MIR4483 | MIR4484 | MIR4485 | MIR4486 | MIR4487 | MIR4488 | MIR4489 | MIR4491 | MIR4492 | MIR4493 | MIR4496 | MIR4497 | MIR4498 | MIR4499 | MIR449A | MIR449B | MIR449C | MIR4500 | MIR4500HG | MIR4501 | MIR4504 | MIR4505 | MIR4506 | MIR4507 | MIR4508 | MIR4509-1 | MIR4509-2 | MIR4509-3 | MIR450A1 | MIR450A2 | MIR450B | MIR4510 | MIR4511 | MIR4512 | MIR4513 | MIR4514 | MIR4516 | MIR4519 | MIR451A | MIR451B | MIR452 | MIR4520-1 | MIR4520-2 | MIR4521 | MIR4524A | MIR4524B
